Dose-Response for Stereotactic Body Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer

Treatment regimens of 10 Gy × 5 and 18 Gy × 3 seem to be efficacious for lung cancer SBRT and provide superior local control and overall survival compared with 9 Gy × 5.